期刊
DRUG DISCOVERY TODAY
卷 16, 期 23-24, 页码 1061-1068出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2011.07.004
关键词
-
资金
- Department of Biotechnology, Government of India [DBT/BT/10382/GBD/27/105/2007]
- India-Australia Biotechnology Fund [BT/Indo-Aus/04/06/2009]
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Centre National de la Recherche Scientifique (CNRS)
- Universite Pierre et Marie Curie
- Universite Paris Descartes
- European Community [260338 ALLFUN]
- Cooperation INSERM-ICMR-AO
Despite remarkable progress in the control of infectious diseases through vaccination, better delivery systems have been poorly explored. There is renewed interest in the discovery of novel vaccines and adjuvants owing to emerging and reemerging diseases and the burden and complexity of chronic infectious diseases. Conversely, the need for rapid local, regional, mucosal or parenteral bioavailability has led to advances in delivery systems and devices. Here, we present recent developments in the field of non-invasive cutaneous delivery of vaccines for infectious diseases. Transdermal delivery using microneedles could revolutionize the way prophylactic interventions for infectious diseases are carried out in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据